Acquirer Profile
Aurinia Pharmaceuticals Acquisitions & Deals (2026)
Biotech
Deals tracked
1
Combined value
$50M
Primary sector
Biotech
Active
2026
FireStrike tracks every Aurinia Pharmaceuticals acquisition, merger, and strategic investment in real time. This page covers 1 Aurinia Pharmaceuticals deals totaling $50M in disclosed deal value, spanning Biotech. Data covers 2026.
Aurinia Pharmaceuticals Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Kezar Life Sciences Biotech | Mar 2026 |
Aurinia Pharmaceuticals Acquisitions — FAQ
How many acquisitions has Aurinia Pharmaceuticals made?
Aurinia Pharmaceuticals has made 1 acquisitions and deals tracked on FireStrike, totaling $50M in combined deal value.
What sectors does Aurinia Pharmaceuticals acquire in?
Aurinia Pharmaceuticals primarily acquires in Biotech.
What is Aurinia Pharmaceuticals's most recent acquisition?
Aurinia Pharmaceuticals's most recent tracked acquisition is Kezar Life Sciences for $50M, announced Mar 2026.
Get every Aurinia Pharmaceuticals deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →